Robin Swartz, Chief Operating Officer at Voyager Therapeutics, Inc. (VYGR), sold 2,188 shares at $9.57 ($22K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Scheduled sale ($22k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.57 | 1,396 | $13K | 62.0% |
| 2 | $10.34 | 792 | $8K | 38.0% |
| Total | $9.85 avg | 2,188 | $22K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |